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Harnessing systemic immune responses for polyomavirus BK involvement in cancer 
development and progression 
Maurizio Provenzano1, Abdou Kamal Allayeh1 
1Oncology Research Unit, Department of Urology and Division of Surgical Research, 
University Hospital of Zurich, Switzerland 
Dear Editor, 
In the manuscript entitled “Tumor growth factor-β is an important factor for 
immunosuppression and tumorigenesis in Polyoma BK virus infection; a systematic review 
article” Ashraf Kariminik and Babak Kheirkhah stress an interesting point about the role of 
TGF-β in the development of polyomavirus BK (BKPyV)-related human malignancies [1]. 
However, in order to better define the interplay between BKPyV carcinogenesis in human and 
TGF-β activity, some passages of this manuscript need to be discussed. The authors state that 
the oncogenic activity of BKPyV is regulated by TGF-β. It is worth noting that TGF-β is mainly 
a tumor promoter “per se” in advanced stages [2], while its role as a tumor suppressor at early 
stages of cancer formation [3] contradicts the review’s claim, if we assume that BKPyV-driven 
carcinogenesis develops at pre-early cancer stages. In addition, studies cited by the authors to 
support the link between the cytokine and the virus have been carried out either in vitro or in 
vivo in animals. For this reason, WHO classified BKPyV as possibly carcinogenic in human 
(group 2A; http://monographs.iarc.fr/ENG/Monograph/vol104/mono104.php). These studies 
are mostly using the middle T oncogene, which is expressed in murine but not in human 
polyomaviruses. Last but not least, the assertion “the higher the viral load, the higher the risk 
of cancer development” is misleading because cancer transformation can occur in infected cells 
during the latent state of BKPyV due to abortive infections [4]. In BKPyV-related human 
cancer, the established regulatory environment characterizing these malignancies might be 
maintained or enhanced by BKPyV. We have recently reported that the main regulatory protein 
LTag was able to reactivate regulatory T cells expressing and releasing both IL-10 and TGF-β 
in BKPyV seropositive prostate cancer patients with BKPyV positive lesions and an aggressive 
phenotype [5]. Therefore, to interpret the existing relationship between TGF-β and BKPyV in 
cancer development, the virus as enhancer of an established regulatory tumor 
microenvironment needs to be factored in.   
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